Evidence map›Paper›PMID 25296321›Full record

ArticleBiophysical journal2014

Computational studies of the effect of the S23D/S24D troponin I mutation on cardiac troponin structural dynamics.

Yuanhua Cheng, Steffen Lindert, Peter Kekenes-Huskey, Vijay S Rao, R John Solaro, Paul R Rosevear, Rommie Amaro, Andrew D McCulloch, J Andrew McCammon, Michael Regnier

Open access · greenAbstract read
In one paragraph

Article in Biophysical journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. NHJournal of cellular signaling · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yuanhua ChengDepartment of Bioengineering, University of Washington, Seattle, Washington; National Biomedical Computational Resource, University of California, San Diego, La Jolla, California.
Steffen LindertNational Biomedical Computational Resource, University of California, San Diego, La Jolla, California; Department of Pharmacology, University of California, San Diego, La Jolla, California.
Peter Kekenes-HuskeyNational Biomedical Computational Resource, University of California, San Diego, La Jolla, California; Department of Pharmacology, University of California, San Diego, La Jolla, California.
Vijay S RaoDepartment of Bioengineering, University of Washington, Seattle, Washington.
R John SolaroDepartment of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Paul R RosevearDepartment of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, Ohio.
Rommie AmaroNational Biomedical Computational Resource, University of California, San Diego, La Jolla, California.
Andrew D McCullochNational Biomedical Computational Resource, University of California, San Diego, La Jolla, California; Department of Bioengineering, University of California, San Diego, La Jolla, California.
J Andrew McCammonNational Biomedical Computational Resource, University of California, San Diego, La Jolla, California; Department of Pharmacology, University of California, San Diego, La Jolla, California.
Michael RegnierDepartment of Bioengineering, University of Washington, Seattle, Washington. Electronic address: mregnier@uw.edu.
University of California San Diego · USUniversity of Washington · USUniversity of Cincinnati · USUniversity of Illinois Chicago · US

Funding

Sarcomeric Modifications and Progressive Cardiac MaladaptationP01HL062426 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SOLARO, R JOHN · 2000 to 2020
$42.4M
National Biomedical Computation Resource - Competitive Revision SupplementP41GM103426 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AMARO, ROMMIE E · 2012 to 2019
$14.0M
UW Center for Translational Muscle Research (Overall Application)P30AR074990 · NIAMS · UNIVERSITY OF WASHINGTON · PI MICHAEL REGNIER · 2019 to 2026
$7.5M
COOPERATIVE THIN FILAMENT ACTIVATION IN STRIATED MUSCLER01HL065497 · NHLBI · UNIVERSITY OF WASHINGTON · PI REGNIER, MICHAEL · 2001 to 2012
$4.5M
Bioengineering Cardiovascular Training GrantT32EB001650 · NIBIB · UNIVERSITY OF WASHINGTON · PI REGNIER, MICHAEL · 2004 to 2019
$3.6M
EFFECT OF R1R2 OVER-EXPRESSION ON CARDIAC FUNCTIONR01HL111197 · NHLBI · UNIVERSITY OF WASHINGTON · PI REGNIER, MICHAEL · 2012 to 2015
$2.3M
Howard Hughes Medical InstituteNHLBI NIH HHS HL-11197NHLBI NIH HHS P01 HL-062426NHLBI NIH HHS P01 HL062426NHLBI NIH HHS R01 HL065497NHLBI NIH HHS R01 HL111197NHLBI NIH HHS R01 HL-65497NIAMS NIH HHS P30 AR074990NIBIB NIH HHS T32 EB001650NIGMS NIH HHS P41 GM103426
6 · The paper itself

Abstract

During β-adrenergic stimulation, cardiac troponin I (cTnI) is phosphorylated by protein kinase A (PKA) at sites S23/S24, located at the N-terminus of cTnI. This phosphorylation has been shown to decrease KCa and pCa50, and weaken the cTnC-cTnI (C-I) interaction. We recently reported that phosphorylation results in an increase in the rate of early, slow phase of relaxation (kREL,slow) and a decrease in its duration (tREL,slow), which speeds up the overall relaxation. However, as the N-terminus of cTnI (residues 1-40) has not been resolved in the whole cardiac troponin (cTn) structure, little is known about the molecular-level behavior within the whole cTn complex upon phosphorylation of the S23/S24 residues of cTnI that results in these changes in function. In this study, we built up the cTn complex structure (including residues cTnC 1-161, cTnI 1-172, and cTnT 236-285) with the N-terminus of cTnI. We performed molecular-dynamics (MD) simulations to elucidate the structural basis of PKA phosphorylation-induced changes in cTn structure and Ca(2+) binding. We found that introducing two phosphomimic mutations into sites S23/S24 had no significant effect on the coordinating residues of Ca(2+) binding site II. However, the overall fluctuation of cTn was increased and the C-I interaction was altered relative to the wild-type model. The most significant changes involved interactions with the N-terminus of cTnI. Interestingly, the phosphomimic mutations led to the formation of intrasubunit interactions between the N-terminus and the inhibitory peptide of cTnI. This may result in altered interactions with cTnC and could explain the increased rate and decreased duration of slow-phase relaxation seen in myofibrils.

Indexed as

Molecular Dynamics SimulationMutationCalciumHumansMutant ProteinsMyocardiumPhosphorylationProtein Structure, TertiaryProtein SubunitsTroponin CTroponin ICalciumMutant ProteinsProtein SubunitsTroponin CTroponin I

Identifiers

PMID25296321
PMCPMC4190606
OpenAlexW2098650992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.